ShuYu Civilian Pharmacy Corp., Ltd.

XSEC:301017 Stock Report

Market Cap: CN¥6.0b

ShuYu Civilian Pharmacy Past Earnings Performance

Past criteria checks 0/6

ShuYu Civilian Pharmacy's earnings have been declining at an average annual rate of -15.6%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 22.2% per year.

Key information

-15.6%

Earnings growth rate

-18.0%

EPS growth rate

Consumer Retailing Industry Growth12.8%
Revenue growth rate22.2%
Return on equity-2.1%
Net Margin-0.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How ShuYu Civilian Pharmacy makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:301017 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 249,735-422,4430
30 Jun 249,748182,4200
31 Mar 249,558792,3970
31 Dec 239,1911332,2820
30 Sep 239,1102612,1820
30 Jun 238,6942572,0580
31 Mar 238,3082441,9190
01 Jan 237,8232291,8320
30 Sep 226,8541351,6570
30 Jun 226,2321391,5580
31 Mar 225,7241271,4560
01 Jan 225,3221151,3290
30 Sep 215,0182031,1550
30 Jun 214,8712331,0640
31 Mar 214,7052411,0600
31 Dec 204,6402161,0330
31 Dec 193,4671119540
31 Dec 182,8881138320

Quality Earnings: 301017 is currently unprofitable.

Growing Profit Margin: 301017 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 301017 is unprofitable, and losses have increased over the past 5 years at a rate of 15.6% per year.

Accelerating Growth: Unable to compare 301017's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 301017 is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (6%).


Return on Equity

High ROE: 301017 has a negative Return on Equity (-2.09%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies